logo
Impact Radar
  • Overview
  • Impact Performance
  • Positions
  • Compare this ETF
    • Sign UpLog In
    logo

    L&G Pharma Breakthrough UCITS ETF | Sustainability & Chart

    ISIN:

    WKN:

    IE00BF0H7608

    Basic information on the L&G Pharma Breakthrough UCITS ETF

    Index
    Solactive Pharma Breakthrough Value Index Net TR USD
    Provider
    L&G
    Asset Class
    Stocks
    Total Expense Ratio (TER)
    0,49%
    Fund Volume
    $ 29 million
    Positions
    44
    Top 10 Weight
    27,23%
    Distribution Policy
    Accumulating
    Replication Method
    Physical
    Launch Date
    15.12.2017
    Fund Currency
    USD

    As of: 01.10.2026

    Website

    Overall Impact Performance

    based on companies in this ETF

    Climate

    30%

    Society

    59%

    Gender

    67%
    knob-globe
    52%

    Impact Score

    Description L&G Pharma Breakthrough UCITS ETF

    Pharmaceutical innovation and healthcare exposure, focused on companies involved in breakthrough drug development and related activities. The fund provides global equity exposure to the pharma sector.

    L&G Pharma Breakthrough UCITS ETF Sustainability Performance

    Renewable Energy
    Greenhouse Gas Emissions
    Supply Chain
    Waste Recycling
    Sustainable [100]
    Almost sustainable [67-99]
    Moderate [34-66]
    Not sustainable [0-33]
    No data
    We measure the sustainability of the ETF based on the weighted average values of companies in the ETF. Each position is included in the overall assessment according to its share in the ETF.Indicators range from 0 to 100: values from 0 to 33 are shown in red (“not sustainable”), values from 34 to 66 in yellow (“moderate”), values from 67 to 99 in light green (“almost sustainable”), and a value of 100 in green (“sustainable”). The ETF evaluation is based on 51.52% of the total ETF volume. In principle, equities and corporate bonds can be evaluated. Other asset classes or positions without available sustainability data were not taken into account. Learn more about our method.

    Positions

    Name
    Weight
    Country
    Industry
    Climate
    Society
    Gender
    Impact Score

    Die größten 10 Positionen des L&G Pharma Breakthrough UCITS ETF machen 27.2291 % des gesamten Fondsvolumens aus.

    Stand: 01.10.2026

    Compare L&G Pharma Breakthrough UCITS ETF with ...

    L&G Pharma Breakthrough UCITS ETF

    ?

    Impact Score

    knob-globe
    52%
    knob-globe
    0%
    Climate
    Society
    Gender

    Find more sustainable ETFs

    logo
    HomeFind Companies & ETFsLearn to investAcademyGlossaryOur Method
    ImprintPrivacy PolicyGTCFAQContact Us
    © 2026 money:care GmbHDisclaimerThe information provided is for informational purposes only and does not constitute an offer, recommendation, or investment advice to buy or sell financial instruments. Nor may they or any part of them be used as a basis for concluding a contract. They have been adopted in good faith from publicly accessible sources. No liability can be assumed for their accuracy. Any financial instrument referred to in this information and documents may be unsuitable for the respective investor to whom it is addressed. The recipients of such information and documents are responsible for independently evaluating and reviewing the products, assets, and financial instruments mentioned therein. Investors must make their own assessment of the suitability of the financial instruments mentioned herein based on the benefits and risks associated with the acquisition of the products, as well as on the basis of their own investment strategy and their legal, tax, and financial situation. Should readers use the content offered or follow any advice, they act on their own responsibility.The information contained in the company descriptions is generated by artificial intelligence and is for informational purposes only. While we strive for accuracy, the content may not be entirely reliable or comprehensive. We recommend cross-referencing the AI-generated content with other reliable sources to verify it and gain a more comprehensive understanding of the respective companies.Some links are affiliate links. If you click on these links and open an account, we will receive a small commission. Don't worry, you won't incur any additional costs. Thank you for your support! Reference data includes information from ESMA FIRDS that has been transformed and enriched by money:care. The use of this reference data does not constitute endorsement of or support for money:care or its products by ESMA. Fund information is based in part on publications by the respective providers and has been processed by money:care. Logos provided by Logo.dev